| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7821 |
| Human Intestinal Absorption | HIA+ | 0.9933 |
| Caco-2 Permeability | Caco2+ | 0.5000 |
| P-glycoprotein Substrate | Substrate | 0.6581 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5900 |
| Non-inhibitor | 0.7750 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7165 |
| Distribution |
| Subcellular localization | Lysosome | 0.4151 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8742 |
| CYP450 2D6 Substrate | Non-substrate | 0.9116 |
| CYP450 3A4 Substrate | Substrate | 0.7407 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7447 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.5566 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6788 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.6998 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6981 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7235 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9760 |
| Non-inhibitor | 0.8734 |
| AMES Toxicity | Non AMES toxic | 0.6466 |
| Carcinogens | Non-carcinogens | 0.9310 |
| Fish Toxicity | High FHMT | 0.6584 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7259 |
| Honey Bee Toxicity | Low HBT | 0.8261 |
| Biodegradation | Not ready biodegradable | 0.8906 |
| Acute Oral Toxicity | III | 0.5913 |
| Carcinogenicity (Three-class) | Non-required | 0.5935 |